Cure MSA

Country specific patient information

Mutations in COQ2 in familial and sporadic multiple-system atrophy. The New England journal of medicine 2013;369:233-244. https://doi.org/10.1056/NEJMoa1212115.

 

Abstracts of Special Session Presentations at the 2013 APS-MSA Joint Meeting. Phytopathology 2013;103:S2170-2192. https://doi.org/10.1094/phyto-103-6-s2.170.

 

Abstracts Submitted for Presentation at the 2013 APS-MSA Joint Meeting. Phytopathology 2013;103:S21-s2169. https://doi.org/10.1094/phyto-103-6-s2.1.

 

Ahmed Z, Asi YT, Lees AJ, Revesz T, Holton JL. Identification and quantification of oligodendrocyte precursor cells in multiple system atrophy, progressive supranuclear palsy and Parkinson's disease. Brain pathology (Zurich, Switzerland) 2013;23:263-273. https://doi.org/10.1111/j.1750-3639.2012.00637.x.

 

Asahina M, Low DA, Mathias CJ, Fujinuma Y, Katagiri A, Yamanaka Y, Shimada J, Poudel A, Kuwabara S. Skin temperature of the hand in multiple system atrophy and Parkinson's disease. Parkinsonism & related disorders 2013;19:560-562. https://doi.org/10.1016/j.parkreldis.2013.01.015.

 

Baeza Trinidad R, Serrano Ponz M. [Multiple system atrophy: hot cross bun and Santiaguino sign]. Rev Clin Esp (Barc) 2014;214:e9. https://doi.org/10.1016/j.rce.2013.08.005.

 

Batla A, Stamelou M, Mensikova K, Kaiserova M, Tuckova L, Kanovsky P, Quinn N, Bhatia KP. Markedly asymmetric presentation in multiple system atrophy. Parkinsonism & related disorders 2013;19:901-905. https://doi.org/10.1016/j.parkreldis.2013.05.004.

 

Baudrexel S, Seifried C, Penndorf B, Klein JC, Middendorp M, Steinmetz H, Grunwald F, Hilker R. The value of putaminal diffusion imaging versus 18-fluorodeoxyglucose positron emission tomography for the differential diagnosis of the Parkinson variant of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2014;29:380-387. https://doi.org/10.1002/mds.25749.

 

Benarroch EE, Schmeichel AM, Low PA, Parisi JE. Parabrachial nucleus involvement in multiple system atrophy. Autonomic neuroscience : basic & clinical 2013;177:170-174. https://doi.org/10.1016/j.autneu.2013.04.007.

 

Bjornsdottir A, Gudmundsson G, Blondal H, Olafsson E. Incidence and prevalence of multiple system atrophy: a nationwide study in Iceland. Journal of neurology, neurosurgery, and psychiatry 2013;84:136-140. https://doi.org/10.1136/jnnp-2012-302500.

 

Bleasel JM, Hsiao JH, Halliday GM, Kim WS. Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins. Journal of Parkinson's disease 2013;3:331-339. https://doi.org/10.3233/jpd-130203.

 

Boudes M, Uvin P, Pinto S, Voets T, Fowler CJ, Wenning GK, De Ridder D, Stefanova N. Bladder dysfunction in a transgenic mouse model of multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2013;28:347-355. https://doi.org/10.1002/mds.25336.

 

Brisinda D, Sorbo AR, Di Giacopo R, Venuti A, Bentivoglio AR, Fenici R. Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy. Journal of the neurological sciences 2014;336:197-202. https://doi.org/10.1016/j.jns.2013.10.039.

 

Brudek T, Winge K, Agander TK, Pakkenberg B. Screening of Toll-like receptors expression in multiple system atrophy brains. Neurochemical research 2013;38:1252-1259. https://doi.org/10.1007/s11064-013-1020-5.

 

Bujan B, Hofer MJ, Oertel WH, Pagenstecher A, Burk K. Multiple system atrophy of the cerebellar type (MSA-C) with concomitant beta-amyloid and tau pathology. Clinical neuropathology 2013;32:286-290. https://doi.org/10.5414/np300572.

 

Calandra-Buonaura G, Guaraldi P, Sambati L, Lopane G, Cecere A, Barletta G, Provini F, Contin M, Martinelli P, Cortelli P. Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2013;34:1875-1878. https://doi.org/10.1007/s10072-013-1470-1.

 

Cao B, Guo X, Chen K, Song W, Huang R, Wei QQ, Zhao B, Shang HF. Uric acid is associated with the prevalence but not disease progression of multiple system atrophy in Chinese population. Journal of neurology 2013;260:2511-2515. https://doi.org/10.1007/s00415-013-7006-z.

 

Cao B, Guo X, Chen K, Song W, Huang R, Wei QQ, Zhao B, Shang HF. Serum lipid levels are associated with the prevalence but not with the disease progression of multiple system atrophy in a Chinese population. Neurological research 2014;36:150-156. https://doi.org/10.1179/1743132813y.0000000277.

 

Ceravolo R, Nicoletti V, Garavaglia B, Reale C, Kiferle L, Bonuccelli U. Expanding the clinical phenotype of DYT5 mutations: is multiple system atrophy a possible one? Neurology 2013;81:301-302. https://doi.org/10.1212/WNL.0b013e31829bfd7c.

 

Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M. Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy. European journal of radiology 2014;83:564-570. https://doi.org/10.1016/j.ejrad.2013.11.024.

 

Cilia R, Siri C, Colombo A, Pezzoli G. Multiple compulsive behaviors in multiple system atrophy: the importance of predisposition to addiction. Parkinsonism & related disorders 2014;20:355-357. https://doi.org/10.1016/j.parkreldis.2013.12.010.

 

Cope TE, Grube M, Singh B, Burn DJ, Griffiths TD. The basal ganglia in perceptual timing: timing performance in Multiple System Atrophy and Huntington's disease. Neuropsychologia 2014;52:73-81. https://doi.org/10.1016/j.neuropsychologia.2013.09.039.

 

Doherty KM, Warner TT, Lees AJ. Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma. Movement disorders : official journal of the Movement Disorder Society 2014;29:36-38. https://doi.org/10.1002/mds.25770.

 

Ferguson MC, Garland EM, Hedges L, Womack-Nunley B, Hamid R, Phillips JA, 3rd, Shibao CA, Raj SR, Biaggioni I, Robertson D. SHC2 gene copy number in multiple system atrophy (MSA). Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2014;24:25-30. https://doi.org/10.1007/s10286-013-0216-8.

 

Fernagut PO, Meissner WG, Biran M, Fantin M, Bassil F, Franconi JM, Tison F. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy. Synapse (New York, NY) 2014;68:98-106. https://doi.org/10.1002/syn.21719.

 

Fischer MD, Synofzik M, Kernstock C, Dietzsch J, Heidlauf R, Schicks J, Srulijes K, Wiethoff S, Menn O, Berg D, Schols L, Schiefer U. Decreased retinal sensitivity and loss of retinal nerve fibers in multiple system atrophy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2013;251:235-241. https://doi.org/10.1007/s00417-012-2118-1.

 

Fogel BL, Baker C, Curnow A, Perlman SL, Geschwind DH, Coppola G. Mutations in PDYN are not responsible for multiple system atrophy. Journal of neurology 2013;260:927-928. https://doi.org/10.1007/s00415-012-6830-x.

 

Foki T, Steininger S, Kasprian G, Wenning GK, Fertl E, Pirker W. An exceptional case of MSA-P. Journal of neurology 2013;260:1171-1173. https://doi.org/10.1007/s00415-013-6875-5.

 

Fukushima T, Asahina M, Fujinuma Y, Yamanaka Y, Katagiri A, Mori M, Kuwabara S. Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy. Journal of neurology 2013;260:475-483. https://doi.org/10.1007/s00415-012-6660-x.

 

Guo XY, Cao B, Lei F, Huang L, Chen K, Song W, Zhao B, Tang X, Shang H. Clinical and polysomnographic features of patients with multiple system atrophy in Southwest China. Sleep & breathing = Schlaf & Atmung 2013;17:1301-1307. https://doi.org/10.1007/s11325-013-0839-y.

 

Han YH, Lee JH, Kang BM, Mun CW, Baik SK, Shin YI, Park KH. Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy. Journal of the neurological sciences 2013;325:29-35. https://doi.org/10.1016/j.jns.2012.11.009.

 

Hayakawa H, Nagai M, Kawanami A, Nakata Y, Nihira T, Ogino M, Takada M, Saido T, Takano J, Saegusa M, Mikami T, Hamada J, Nishiyama K, Mochizuki H, Mizuno Y. Loss of DARPP-32 and calbindin in multiple system atrophy. Journal of neural transmission (Vienna, Austria : 1996) 2013;120:1689-1698. https://doi.org/10.1007/s00702-013-1039-4.

 

Herbert MK, Eeftens JM, Aerts MB, Esselink RA, Bloem BR, Kuiperij HB, Verbeek MM. CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls. Parkinsonism & related disorders 2014;20:112-115. https://doi.org/10.1016/j.parkreldis.2013.09.003.

 

Kaasinen V, Gardberg M, Seppanen M, Roytta M, Parkkola R, Bergman J. Brain glucose metabolism in neuropathologically confirmed multiple system atrophy. Journal of neurology 2013;260:1922-1924. https://doi.org/10.1007/s00415-013-6967-2.

 

Kaindlstorfer C, Granata R, Wenning GK. Tremor in Multiple System Atrophy - a review. Tremor and other hyperkinetic movements (New York, NY) 2013;3. https://doi.org/10.7916/d8nv9gz9.

 

Kaufman E, Hall S, Surova Y, Widner H, Hansson O, Lindqvist D. Proinflammatory cytokines are elevated in serum of patients with multiple system atrophy. PloS one 2013;8:e62354. https://doi.org/10.1371/journal.pone.0062354.

 

Kawashima S, Ueki Y, Mima T, Fukuyama H, Ojika K, Matsukawa N. Differences in dopaminergic modulation to motor cortical plasticity between Parkinson's disease and multiple system atrophy. PloS one 2013;8:e62515. https://doi.org/10.1371/journal.pone.0062515.

 

Kiely AP, Asi YT, Kara E, Limousin P, Ling H, Lewis P, Proukakis C, Quinn N, Lees AJ, Hardy J, Revesz T, Houlden H, Holton JL. alpha-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta neuropathologica 2013;125:753-769. https://doi.org/10.1007/s00401-013-1096-7.

 

Kim HJ, Jeon BS, Kim YE, Kim JY, Kim YK, Sohn CH, Yun JY, Jeon S, Lee JM, Lee JY. Clinical and imaging characteristics of dementia in multiple system atrophy. Parkinsonism & related disorders 2013;19:617-621. https://doi.org/10.1016/j.parkreldis.2013.02.012.

 

Kim JS, Youn J, Yang JJ, Lee DK, Lee JM, Kim ST, Kim HT, Cho JW. Topographic distribution of cortical thinning in subtypes of multiple system atrophy. Parkinsonism & related disorders 2013;19:970-974. https://doi.org/10.1016/j.parkreldis.2013.06.012.

 

Kon T, Mori F, Tanji K, Miki Y, Wakabayashi K. An autopsy case of preclinical multiple system atrophy (MSA-C). Neuropathology : official journal of the Japanese Society of Neuropathology 2013;33:667-672. https://doi.org/10.1111/neup.12037.

 

Kragh CL, Fillon G, Gysbers A, Hansen HD, Neumann M, Richter-Landsberg C, Haass C, Zalc B, Lubetzki C, Gai WP, Halliday GM, Kahle PJ, Jensen PH. FAS-dependent cell death in alpha-synuclein transgenic oligodendrocyte models of multiple system atrophy. PloS one 2013;8:e55243. https://doi.org/10.1371/journal.pone.0055243.

 

Kragh CL, Gysbers AM, Rockenstein E, Murphy K, Halliday GM, Masliah E, Jensen PH. Prodegenerative IkappaBalpha expression in oligodendroglial alpha-synuclein models of multiple system atrophy. Neurobiology of disease 2014;63:171-183. https://doi.org/10.1016/j.nbd.2013.12.002.

 

Krismer F, Duerr S, Minnerop M, Klockgether T, Stamelou M, Eggert KM, Oertel WH, Schrag A, Poewe W, Wenning GK. [MSA-QoL: disease-specific questionnaire to assess health-related quality of life in multiple system atrophy: validation of the German translation]. Der Nervenarzt 2013;84:709-714. https://doi.org/10.1007/s00115-013-3764-1.

 

Krismer F, Wenning GK, Li Y, Poewe W, Stefanova N. Intact olfaction in a mouse model of multiple system atrophy. PloS one 2013;8:e64625. https://doi.org/10.1371/journal.pone.0064625.

 

Kuzdas D, Stemberger S, Gaburro S, Stefanova N, Singewald N, Wenning GK. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence. Experimental neurology 2013;247:531-536. https://doi.org/10.1016/j.expneurol.2013.02.002.

 

Lalich IJ, Ekbom DC, Starkman SJ, Orbelo DM, Morgenthaler TI. Vocal fold motion impairment in multiple system atrophy. The Laryngoscope 2014;124:730-735. https://doi.org/10.1002/lary.24402.

 

Lee JE, Song SK, Hong JY, Sunwoo MK, Park HJ, Sohn YH, Lee PH. Changes in the blood-brain barrier status closely correlate with the rate of disease progression in patients with multiple system atrophy: a longitudinal study. Parkinsonism & related disorders 2013;19:450-452. https://doi.org/10.1016/j.parkreldis.2012.12.002.

 

Lee JH, Han YH, Kang BM, Mun CW, Lee SJ, Baik SK. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy. Journal of neurology 2013;260:2094-2101. https://doi.org/10.1007/s00415-013-6951-x.

 

Ling H, Petrovic IN, Lang AE, Lees AJ. Reply to letter: Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch. Movement disorders : official journal of the Movement Disorder Society 2013;28:408. https://doi.org/10.1002/mds.25288.

 

Lloyd-Smith A, Jacova P, Schulzer M, Spacey SD. Early clinical features differentiate cerebellar variant MSA and sporadic ataxia. The Canadian journal of neurological sciences Le journal canadien des sciences neurologiques 2013;40:252-254.

Lozano JM, Guerrero YA, Alba MP, Lesmes LP, Escobar JO, Patarroyo ME. Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds. Amino acids 2013;45:913-935. https://doi.org/10.1007/s00726-013-1541-x.

 

Lu CF, Soong BW, Wu HM, Teng S, Wang PS, Wu YT. Disrupted cerebellar connectivity reduces whole-brain network efficiency in multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2013;28:362-369. https://doi.org/10.1002/mds.25314.

 

Lu CF, Wang PS, Lao YL, Wu HM, Soong BW, Wu YT. Medullo-ponto-cerebellar white matter degeneration altered brain network organization and cortical morphology in multiple system atrophy. Brain structure & function 2014;219:947-958. https://doi.org/10.1007/s00429-013-0545-3.

 

Matsuura K, Maeda M, Yata K, Ichiba Y, Yamaguchi T, Kanamaru K, Tomimoto H. Neuromelanin magnetic resonance imaging in Parkinson's disease and multiple system atrophy. European neurology 2013;70:70-77. https://doi.org/10.1159/000350291.

 

Mazere J, Meissner WG, Sibon I, Lamare F, Tison F, Allard M, Mayo W. [(123)I]-IBVM SPECT imaging of cholinergic systems in multiple system atrophy: A specific alteration of the ponto-thalamic cholinergic pathways (Ch5-Ch6). NeuroImage Clinical 2013;3:212-217. https://doi.org/10.1016/j.nicl.2013.07.012.

 

Meissner WG, Foubert-Samier A, Dupouy S, Debs R, Gerdelat-Mas A, Cochen De Cock V, Schrag A, Rascol O, Tison F, Pavy-Le Traon A. Validation of the French version of the MSA health-related Quality of Life scale (MSA-QoL). Revue neurologique 2013;169:53-58. https://doi.org/10.1016/j.neurol.2012.02.011.

 

Muntean ML, Sixel-Doring F, Trenkwalder C. No Difference in Sleep and RBD between Different Types of Patients with Multiple System Atrophy: A Pilot Video-Polysomnographical Study. Sleep disorders 2013;2013:258390. https://doi.org/10.1155/2013/258390.

 

Nagano D, Sivakumar T, De De Macedo AC, Inpankaew T, Alhassan A, Igarashi I, Yokoyama N. The genetic diversity of merozoite surface antigen 1 (MSA-1) among Babesia bovis detected from cattle populations in Thailand, Brazil and Ghana. The Journal of veterinary medical science 2013;75:1463-1470.

Nair SR, Tan LK, Mohd Ramli N, Lim SY, Rahmat K, Mohd Nor H. A decision tree for differentiating multiple system atrophy from Parkinson's disease using 3-T MR imaging. European radiology 2013;23:1459-1466. https://doi.org/10.1007/s00330-012-2759-9.

 

Nicoletti G, Rizzo G, Barbagallo G, Tonon C, Condino F, Manners D, Messina D, Testa C, Arabia G, Gambardella A, Lodi R, Quattrone A. Diffusivity of cerebellar hemispheres enables discrimination of cerebellar or parkinsonian multiple system atrophy from progressive supranuclear palsy-Richardson syndrome and Parkinson disease. Radiology 2013;267:843-850. https://doi.org/10.1148/radiol.12120364.

 

Numao A, Suzuki K, Miyamoto M, Miyamoto T, Hirata K. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. Parkinsonism & related disorders 2014;20:212-216. https://doi.org/10.1016/j.parkreldis.2013.11.005.

 

Ozawa T. The COQ2 mutations in Japanese multiple system atrophy: impact on the pathogenesis and phenotypic variation. Movement disorders : official journal of the Movement Disorder Society 2014;29:184. https://doi.org/10.1002/mds.25685.

 

Ozawa T, Tokunaga J, Arakawa M, Ishikawa A, Takeuchi R, Mezaki N, Miura T, Sakai N, Hokari M, Takeshima A, Utsumi K, Kondo T, Yokoseki A, Nishizawa M. Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients. Journal of neurology 2013;260:2073-2077. https://doi.org/10.1007/s00415-013-6944-9.

 

Pedroso JL, Rivero RL, Barsottini OG. "Hot cross bun" sign resembling multiple system atrophy in a patient with Machado-Joseph disease. Arquivos de neuro-psiquiatria 2013;71:824. https://doi.org/10.1590/0004-282x20130132.

 

Perrotta A, Bolla M, Serrao M, Paparatti M, Tassorelli C, Pierelli F, Sandrini G. Enhanced temporal pain processing in multiple system atrophy. Neuroscience letters 2013;555:203-208. https://doi.org/10.1016/j.neulet.2013.09.035.

 

Pilleri M, Levedianos G, Weis L, Gasparoli E, Facchini S, Biundo R, Formento-Dojot P, Antonini A. Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy. Parkinsonism & related disorders 2014;20:217-221. https://doi.org/10.1016/j.parkreldis.2013.11.006.

 

Qi XK, Song DD. [Pay attentions to the clinical research and diagnostic strategy in multiple system atrophy]. Zhonghua nei ke za zhi 2013;52:918-919.

Qi XK, Zhang HL, Cui LY. [Pay attention to nonmotor symptoms and electrophysiological diagnostic methods for the patients of multiple system atrophy]. Zhonghua yi xue za zhi 2013;93:1937-1939.

Qiu F, Liu JG, Li LP, Song DD, Yao W, Qi XK. [Comparative study on diagnostic significance of urethral sphincter versus external anal sphincter electromyography in patients with multiple system atrophy]. Zhonghua yi xue za zhi 2013;93:1958-1961.

Reginold W, Lang AE, Marras C, Heyn C, Alharbi M, Mikulis DJ. Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy. Parkinsonism & related disorders 2014;20:222-225. https://doi.org/10.1016/j.parkreldis.2013.10.002.

 

Regragui W, Lachhab L, Razine R, Benjelloun H, Ait Benhaddou EH, Benomar A, Yahyaoui M. Profile of multiple system atrophy in Moroccan patients attending a movement disorders outpatient clinic in Rabat university hospital. Revue neurologique 2013;169:121-125. https://doi.org/10.1016/j.neurol.2012.04.006.

 

Ren Y, Wang Y, Liu H, Yan H, Chen J, Hou M, Li W, Fan Y, Zhou Q. [Influence of MSA on cell growth and spontaneousn metastasis of L9981-Luc lung cancer transplanted model in nude mice by bioluminescence imaging]. Zhongguo fei ai za zhi = Chinese journal of lung cancer 2013;16:67-72. https://doi.org/10.3779/j.issn.1009-3419.2013.02.02.

 

Rocchi L, Conte A, Nardella A, Li Voti P, Di Biasio F, Leodori G, Fabbrini G, Berardelli A. Somatosensory temporal discrimination threshold may help to differentiate patients with multiple system atrophy from patients with Parkinson's disease. European journal of neurology 2013;20:714-719. https://doi.org/10.1111/ene.12059.

 

Rodriguez AE, Zamorano P, Wilkowsky S, Torra F, Ferreri L, Dominguez M, Florin-Christensen M. Delivery of recombinant vaccines against bovine herpesvirus type 1 gD and Babesia bovis MSA-2c to mice using liposomes derived from egg yolk lipids. Veterinary journal (London, England : 1997) 2013;196:550-551. https://doi.org/10.1016/j.tvjl.2012.10.036.

 

Roncevic D, Palma JA, Martinez J, Goulding N, Norcliffe-Kaufmann L, Kaufmann H. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival. Journal of neural transmission (Vienna, Austria : 1996) 2014;121:507-512. https://doi.org/10.1007/s00702-013-1133-7.

 

Sacca F, Marsili A, Quarantelli M, Brescia Morra V, Brunetti A, Carbone R, Pane C, Puorro G, Russo CV, Salvatore E, Tucci T, De Michele G, Filla A. A randomized clinical trial of lithium in multiple system atrophy. Journal of neurology 2013;260:458-461. https://doi.org/10.1007/s00415-012-6655-7.

 

Shigemoto Y, Matsuda H, Kamiya K, Maikusa N, Nakata Y, Ito K, Ota M, Matsunaga N, Sato N. In vivo evaluation of gray and white matter volume loss in the parkinsonian variant of multiple system atrophy using SPM8 plus DARTEL for VBM. NeuroImage Clinical 2013;2:491-496. https://doi.org/10.1016/j.nicl.2013.03.017.

 

Shihman B, Giladi N, Bleiberg M, Rosenberg A, Korczyn AD, Gurevich T. Elevated titers of anti-thyroperoxidase antibodies in patients with multiple system atrophy: a pilot study. Clinical neurology and neurosurgery 2013;115:2348-2350. https://doi.org/10.1016/j.clineuro.2013.08.013.

 

Simking P, Saengow S, Bangphoomi K, Sarataphan N, Wongnarkpet S, Inpankaew T, Jittapalapong S, Munkhjargal T, Sivakumar T, Yokoyama N, Igarashi I. The molecular prevalence and MSA-2b gene-based genetic diversity of Babesia bovis in dairy cattle in Thailand. Veterinary parasitology 2013;197:642-648. https://doi.org/10.1016/j.vetpar.2013.07.015.

 

Singh K, Suri R, Tiwary AK, Rana V. Exploiting the synergistic effect of chitosan-EDTA conjugate with MSA for the early recovery from colitis. International journal of biological macromolecules 2013;54:186-196. https://doi.org/10.1016/j.ijbiomac.2012.12.026.

 

Siri C, Duerr S, Canesi M, Delazer M, Esselink R, Bloem BR, Gurevich T, Balas M, Giladi N, Santacruz P, Marti F, Tolosa E, Rubino A, Meco G, Poewe W, Pezzoli G, Wenning G, Antonini A. A cross-sectional multicenter study of cognitive and behavioural features in multiple system atrophy patients of the parkinsonian and cerebellar type. Journal of neural transmission (Vienna, Austria : 1996) 2013;120:613-618. https://doi.org/10.1007/s00702-013-0997-x.

 

Song DD, Yu YX, Dong QW, Zhang HL, Liu JG, Liu Q, Yu J, Qi XK. [Assessment of cognitive function, emotions and activities of daily living in patients with multiple system atrophy]. Zhonghua yi xue za zhi 2013;93:1948-1951.

Spaccavento S, Del Prete M, Loverre A, Craca A, Nardulli R. Multiple system atrophy with early cognitive deficits: a case report. Neurocase 2013;19:613-622. https://doi.org/10.1080/13554794.2012.713494.

 

Srulijes K, Hauser AK, Guella I, Asselta R, Brockmann K, Schulte C, Solda G, Cilia R, Maetzler W, Schols L, Wenning GK, Poewe W, Barone P, Wullner U, Oertel W, Berg D, Goldwurm S, Gasser T. No association of GBA mutations and multiple system atrophy. European journal of neurology 2013;20:e61-62. https://doi.org/10.1111/ene.12086.

 

Stamelou M, Quinn NP, Bhatia KP. "Atypical" atypical parkinsonism: new genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy-a diagnostic guide. Movement disorders : official journal of the Movement Disorder Society 2013;28:1184-1199. https://doi.org/10.1002/mds.25509.

 

Stetkarova I, Kofler M, Majerova V. Cutaneous silent periods in multiple system atrophy. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2015;159:327-332. https://doi.org/10.5507/bp.2013.081.

 

Sun QY, Guo JF, Han WW, Zuo X, Wang L, Yao LY, Pan Q, Xia K, Yan XX, Tang BS. Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2013;20:217-219. https://doi.org/10.1016/j.jocn.2012.01.055.

 

Sun ZF, Xiang XS, Chen Z, Zhang L, Tang BS, Xia K, Jiang H. Increase of the plasma alpha-synuclein levels in patients with multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2014;29:375-379. https://doi.org/10.1002/mds.25688.

 

Suppa A, Marsili L, Di Stasio F, Latorre A, Parvez AK, Colosimo C, Berardelli A. Primary motor cortex long-term plasticity in multiple system atrophy. Movement disorders : official journal of the Movement Disorder Society 2014;29:97-104. https://doi.org/10.1002/mds.25668.

 

Tanji K, Odagiri S, Maruyama A, Mori F, Kakita A, Takahashi H, Wakabayashi K. Alteration of autophagosomal proteins in the brain of multiple system atrophy. Neurobiology of disease 2013;49:190-198. https://doi.org/10.1016/j.nbd.2012.08.017.

 

Ubhi K, Rockenstein E, Kragh C, Inglis C, Spencer B, Michael S, Mante M, Adame A, Galasko D, Masliah E. Widespread microRNA dysregulation in multiple system atrophy - disease-related alteration in miR-96. The European journal of neuroscience 2014;39:1026-1041. https://doi.org/10.1111/ejn.12444.

 

Ueda M, Nakajima N, Nagayama H, Nishiyama Y, Ishii K, Katayama Y. Therapeutic response to pramipexole in a patient with multiple system atrophy with predominant parkinsonism: positron emission tomography and pharmacokinetic assessments. Internal medicine (Tokyo, Japan) 2013;52:1731-1735.

Umemura A, Oeda T, Hayashi R, Tomita S, Kohsaka M, Yamamoto K, Sawada H. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease. PloS one 2013;8:e61066. https://doi.org/10.1371/journal.pone.0061066.

 

Valera E, Ubhi K, Mante M, Rockenstein E, Masliah E. Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy. Glia 2014;62:317-337. https://doi.org/10.1002/glia.22610.

 

Visanji NP, Collingwood JF, Finnegan ME, Tandon A, House E, Hazrati LN. Iron deficiency in parkinsonism: region-specific iron dysregulation in Parkinson's disease and multiple system atrophy. Journal of Parkinson's disease 2013;3:523-537. https://doi.org/10.3233/jpd-130197.

 

von Lewinski F, Schwan M, Paulus W, Trenkwalder C, Sommer M. Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndrome. BMJ open 2013;3:e003098. https://doi.org/10.1136/bmjopen-2013-003098.

 

Watanabe H, Sobue G. A milestone on the way to therapy for MSA. The Lancet Neurology 2013;12:222-223. https://doi.org/10.1016/s1474-4422(13)70023-1.

 

Watts JC, Giles K, Oehler A, Middleton L, Dexter DT, Gentleman SM, DeArmond SJ, Prusiner SB. Transmission of multiple system atrophy prions to transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 2013;110:19555-19560. https://doi.org/10.1073/pnas.1318268110.

 

Wenning GK, Geser F, Krismer F, Seppi K, Duerr S, Boesch S, Kollensperger M, Goebel G, Pfeiffer KP, Barone P, Pellecchia MT, Quinn NP, Koukouni V, Fowler CJ, Schrag A, Mathias CJ, Giladi N, Gurevich T, Dupont E, Ostergaard K, Nilsson CF, Widner H, Oertel W, Eggert KM, Albanese A, del Sorbo F, Tolosa E, Cardozo A, Deuschl G, Hellriegel H, Klockgether T, Dodel R, Sampaio C, Coelho M, Djaldetti R, Melamed E, Gasser T, Kamm C, Meco G, Colosimo C, Rascol O, Meissner WG, Tison F, Poewe W. The natural history of multiple system atrophy: a prospective European cohort study. The Lancet Neurology 2013;12:264-274. https://doi.org/10.1016/s1474-4422(12)70327-7.

 

Wenning GK, Krismer F. Multiple system atrophy. Handbook of clinical neurology 2013;117:229-241. https://doi.org/10.1016/b978-0-444-53491-0.00019-5.

 

Wu SH, Yang HX, Jiang GH, Gong DR, Wang LX. Preliminary results of cord blood mononuclear cell therapy for multiple system atrophy: a report of three cases. Medical principles and practice : international journal of the Kuwait University, Health Science Centre 2014;23:282-285. https://doi.org/10.1159/000354051.

 

Xi H, Chen L, Huang H, Zhang F, Liu Y, Chen D, Xiao J. Preliminary report of multiple cell therapy for patients with multiple system atrophy. Cell transplantation 2013;22 Suppl 1:S93-99. https://doi.org/10.3727/096368913x672145.

 

Xu WH, Wang H, Hu YH, Wang B, Chen J, Gao S. Supine-to-standing transcranial Doppler test in patients with multiple system atrophy. Parkinsonism & related disorders 2013;19:539-542. https://doi.org/10.1016/j.parkreldis.2013.01.021.

 

Yabe I, Sasaki H. [Chromosomal structural variation -- an approach for multiple system atrophy]. Rinsho shinkeigaku = Clinical neurology 2013;53:1333-1335.

Yamamoto T, Sakakibara R, Uchiyama T, Yamaguchi C, Ohno S, Nomura F, Yanagisawa M, Hattori T, Kuwabara S. Time-dependent changes and gender differences in urinary dysfunction in patients with multiple system atrophy. Neurourology and urodynamics 2014;33:516-523. https://doi.org/10.1002/nau.22441.

 

Zhang LW, Gu WH, Wang GX, Chen YY, Hao Y, Zhang J, Wang K, Jin M. [Analysis of fragile X mental retardation 1 gene premutation in multiple system atrophy patients]. Zhonghua yi xue za zhi 2013;93:3744-3747.

Zhao T, Severijnen LA, van der Weiden M, Zheng PP, Oostra BA, Hukema RK, Willemsen R, Kros JM, Bonifati V. FBXO7 immunoreactivity in alpha-synuclein-containing inclusions in Parkinson disease and multiple system atrophy. Journal of neuropathology and experimental neurology 2013;72:482-488. https://doi.org/10.1097/NEN.0b013e318293c586.

 

Zoetmulder M, Biernat HB, Nikolic M, Korbo L, Jennum PJ. Sensorimotor gating deficits in multiple system atrophy: comparison with Parkinson's disease and idiopathic REM sleep behavior disorder. Parkinsonism & related disorders 2014;20:297-302. https://doi.org/10.1016/j.parkreldis.2013.11.018.